Skip to main content
P10015/SARC033: A phase 2 trial of trametinib in patients with advanced epithelioid hemangioendothelioma (EHE). Schuetze, S., Ballman, K. V., Ganjoo, K. N., Davis, E. J., Morgan, J. A., Tinoco, G., Burgess, M., Van Tine, B., Choy, E., Shepard, D., Kelly, C., Riedel, R. F., von Mehren, M., Siontis, B. L., Attia, S., Schwartz, G. K., Deshpande, H., Kozlowski, E., Chen, H. X., Rubin, B. LIPPINCOTT WILLIAMS & WILKINS. 2021

View details for DOI 10.1200/JCO.2021.39.15_suppl.11503

View details for Web of Science ID 000708120606040